Shuang Ma
Mongolian University of Science and Technology(MN)University of International Business and Economics(CN)Dalian Medical University(CN)Sheng Jing Hospital(CN)Zhejiang Lab(CN)First Hospital of China Medical University(CN)First Affiliated Hospital of Dalian Medical University(CN)Qiqihar Medical University(CN)China Medical University(CN)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, RNA Interference and Gene Delivery, Ubiquitin and proteasome pathways, Sarcoma Diagnosis and Treatment, Immunotherapy and Immune Responses
Most-Cited Works
- → Structure–Activity Relationship Studies of Pyrazolo[3,4-d]pyrimidine Derivatives Leading to the Discovery of a Novel Multikinase Inhibitor That Potently Inhibits FLT3 and VEGFR2 and Evaluation of Its Activity against Acute Myeloid Leukemia in Vitro and in Vivo(2013)67 cited
- → A glutathione-activatable nanoplatform for enhanced photodynamic therapy with simultaneous hypoxia relief and glutathione depletion(2020)66 cited
- → Estimating load spectra probability distributions of train bogie frames by the diffusion-based kernel density method(2019)57 cited
- → Spatial and Temporal Changes in Prevalence of Obesity Among Chinese Children and Adolescents, 1985–2005(2019)55 cited
- → Quantitative Diagnosis of Rotor Vibration Fault Using Process Power Spectrum Entropy and Support Vector Machine Method(2014)45 cited
- → Discovery of N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine derivatives as novel CK1 inhibitors using common-feature pharmacophore model based virtual screening and hit-to-lead optimization